Auriga Reiteratess a 'Hold' on Laboratory Corporation (LH); Expect In-line to Slightly Better 4Q Results
Tweet Send to a FriendGet Alerts LH Hot Sheet
Price: $100.01 -0.76%
Rating Summary:
4 Buy, 18 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Rating Summary:
4 Buy, 18 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Trade LH Now!
Auriga reiteratess a 'Hold' on Laboratory Corporation of America (NYSE: LH) price target of $91.00.
Auriga analyst says, "Based on recent results by LH’s largest peer Quest Diagnostics (NYSE: DGX)(Hold Rated) there is a strong possibility that LH may beat our/consensus revenue/EPS estimates for 4Q mainly on improving volume trends. Furthermore, DGX indicated on its call that physician office visits appear to have stabilized, but stopped short from calling it an uptrend. This is a positive data point, which we take into consideration when modeling our 2012 results. That being said, until we confirm a “true” uptrend in lab test volumes we are not willing to assign multiple higher than 13x to derive our price target."
For an analyst ratings summary and ratings history on Laboratory Corporation of America click here. For more ratings news on Laboratory Corporation of America click here.
Shares of Laboratory Corporation of America closed at $91.99 yesterday, with a 52 week range of $74.57-$100.94.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Auriga analyst says, "Based on recent results by LH’s largest peer Quest Diagnostics (NYSE: DGX)(Hold Rated) there is a strong possibility that LH may beat our/consensus revenue/EPS estimates for 4Q mainly on improving volume trends. Furthermore, DGX indicated on its call that physician office visits appear to have stabilized, but stopped short from calling it an uptrend. This is a positive data point, which we take into consideration when modeling our 2012 results. That being said, until we confirm a “true” uptrend in lab test volumes we are not willing to assign multiple higher than 13x to derive our price target."
For an analyst ratings summary and ratings history on Laboratory Corporation of America click here. For more ratings news on Laboratory Corporation of America click here.
Shares of Laboratory Corporation of America closed at $91.99 yesterday, with a 52 week range of $74.57-$100.94.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Morgan Stanley Maintains Bullish Stance on Walter Energy (WLT)
- UPDATE: Bernstein Cuts BlackBerry (BBRY) to Underperform; Notes Weak BB10 Traction
- Wedbush Starts USG Corp. (USG) at Neutral
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
Auriga
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
